Glimisave M3 850 Tablet PR
By Glimisave M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(3mg) + Metformin(850mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
June, 2026

liver
When using Glimisave M3 850 Tablet PR, be cautious if you have liver disease. It may be necessary to adjust the dosage of the medication, so it's important to consult your doctor before starting treatment. Typically, Glimisave M3 850 Tablet PR is initiated at a low dose for individuals with mild to moderate liver disease. However, it is advisable to avoid using this medication if you have severe liver disease.

kidney
Caution should be exercised when using Glimisave M3 850 Tablet PR in patients with kidney disease. Dose adjustment may be necessary, and it is not recommended for those with severe kidney issues. Regular kidney function tests are advised during the treatment.

alcohol
It is not safe to drink alcohol while taking Glimisave M3 850 Tablet PR. It is not recommended as it may cause harmful effects on the body. Consult your doctor when consuming alcohol with Glimisave M3 850 Tablet PR.

driving
Caution When your blood sugar is too low or high, avoid driving due to potential impact on focus and reaction time.

pregnancy
During pregnancy, it is best to avoid using Glimisave M3 850 Tablet PR as it may be unsafe. Animal studies have shown potential harm to the developing baby, and there is limited human study data available. Please consult your doctor for personalized advice.

breastfeeding
Caution should be taken while breastfeeding and using Glimisave M3 850 Tablet PR as it may harm the baby due to potential toxicity.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹190.05
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024